A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma
Bartlett, Nancy L., Herrera, Alex F., Domingo-Domenech, Eva, Mehta, Amitkumar, Forero-Torres, Andres, Garcia-Sanz, Ramon, Armand, Philippe, Devata, Sumana, Izquierdo, Antonia Rodriguez, Lossos, Izidore S., Reeder, Craig, Sher, Taimur, Chen, Robert, Schwarz, Sylvia E., Alland, Leila, Strassz, Andras, Prier, Kim, Choe-Juliak, Cassandra, Ansell, Stephen M.
Published in Blood (19.11.2020)
Published in Blood (19.11.2020)
Get full text
Journal Article
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma
Vogl, Dan T, Dingli, David, Cornell, Robert Frank, Huff, Carol Ann, Jagannath, Sundar, Bhutani, Divaya, Zonder, Jeffrey, Baz, Rachid, Nooka, Ajay, Richter, Joshua, Cole, Craig, Vij, Ravi, Jakubowiak, Andrzej, Abonour, Rafat, Schiller, Gary, Parker, Terri L, Costa, Luciano J, Kaminetzky, David, Hoffman, James E, Yee, Andrew J, Chari, Ajai, Siegel, David, Fonseca, Rafael, Van Wier, Scott, Ahmann, Gregory, Lopez, Ilsel, Kauffman, Michael, Shacham, Sharon, Saint-Martin, Jean-Richard, Picklesimer, Carla D, Choe-Juliak, Cassandra, Stewart, A Keith
Published in Journal of clinical oncology (20.03.2018)
Published in Journal of clinical oncology (20.03.2018)
Get full text
Journal Article
A phase II open-label multicenter study to assess the efficacy and safety of AFM13 in patients with relapsed or refractory CD30-positive peripheral T-cell lymphoma or transformed mycosis fungoides: The REDIRECT study design and rationale
Choe-Juliak, Cassandra, Alexis, Karenza M., Schwarz, Sylvia, Garcia, Linta, Sawas, Ahmed
Published in Journal of clinical oncology (20.05.2020)
Published in Journal of clinical oncology (20.05.2020)
Get full text
Journal Article
Abstract 1881: AFM24 is a novel, highly potent, tetravalent bispecific EGFR/CD16A-targeting Innate Cell Engager (ICE®) designed for the treatment of EGFR-positive malignancies
Pahl, Jens, Hintzen, Gabriele, Reusch, Uwe, Haneke, Torsten, Breunig, Christian, Pinto, Sheena, Choe-Juliak, Cassandra, Harstrick, Andreas, Fischer, Wolfgang, Schottelius, Arndt, Koch, Joachim, Rajkovic, Erich
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Published in Cancer research (Chicago, Ill.) (01.07.2021)
Get full text
Journal Article
A Phase 1 Study Investigating AFM11 in Patients with Relapsed/Refractory B Cell Precursor Acute Lymphoblastic Leukemia: Preliminary Results
Salogub, Galina, Mayer, Jiri, Folber, Frantisek, Grosicki, Sebastian, Skotnicki, Aleksander B, Prochwicz, Anna, Myasnikov, Alexander, Gural, Alexander, Schoenborn-Kellenberger, Oliver, Brindley, Charlie, Knackmuss, Stefan, Schwarz, Sylvia, Schmich, Sandra, Choe-Juliak, Cassandra, Strassz, Andras, Alland, Leila, Doubek, Michael
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
A Phase 1b Study Investigating the Combination of the Tetravalent Bispecific NK Cell Engager AFM13 and Pembrolizumab in Patients with Relapsed/Refractory Hodgkin Lymphoma after Brentuximab Vedotin Failure: Updated Safety and Efficacy Data
Bartlett, Nancy L., Chen, Robert W., Domingo-Domenech, Eva, Forero-Torres, Andres, Garcia-Sanz, Ramon, Armand, Philippe, Devata, Sumana, Rodriguez Izquierdo, Antonia, Lossos, Izidore S., Reeder, Craig B., Sher, Taimur, Choe-Juliak, Cassandra, Prier, Kim, Schwarz, Sylvia, Strassz, Andras, Alland, Leila, Ansell, Stephen M.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
The Selinexor in Advanced Liposarcoma (SEAL) study: A phase 2/3, multicenter, randomized, double blind study of selinexor versus placebo in patients with advanced, unresectable, dedifferentiated liposarcoma (DDLS)
Gounder, Mrinal M., Wagner, Andrew J., Somaiah, Neeta, Riedel, Richard F., Schwartz, Gary K., Attia, Steven, Razak, Albiruni R.A., Cranmer, Lee D., Okuno, Scott H., Milhem, Mohammed M., Choe-Juliak, Cassandra, Shacham, Sharon, Kauffman, Michael G., Chawla, Sant P.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A Phase 1/2 Study of the Second Generation Selective Inhibitor of Nuclear Export (SINE) Compound, KPT-8602, in Patients with Relapsed Refractory Multiple Myeloma
Cornell, R. Frank, Rossi, Adriana C, Baz, Rachid, Hofmeister, Craig C, Shustik, Chaim, Richter, Joshua R., Chen, Christine, Vogl, Dan T., Shacham, Sharon, Baloglu, Erkan, Senapedis, William, Ellis, Joel, Friedlander, Sharon, Choe-Juliak, Cassandra, Cubitt, Christopher L, Turner, Joel G, Sullivan, Daniel, Kauffman, Michael
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Selinexor Shows Synergy in Combination with Pomalidomide and Low Dose Dexamethasone in Patients with Relapsed / Refractory Multiple Myeloma
Chen, Christine, Kotb, Rami, Sebag, Michael, LeBlanc, Richard, Sutherland, Heather J., White, Darrell, Venner, Christopher P., Kouroukis, Tom, Bergstrom, Debra, McCurdy, Arleigh, Lalancette, Marc, Bensinger, William, Lentzsch, Suzanne, Del Col, Aldo, Kauffman, Michael, Shacham, Sharon, Jeha, Jacqueline, Picklesimer, Carla, Saint-Martin, Jean-Richard, Choe-Juliak, Cassandra, Bahlis, Nizar J.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Selinexor in Combination with Bortezomib and Dexamethasone (SdB) Demonstrates Significant Activity in Patients with Refractory Multiple Myeloma (MM) Including Proteasome-Inhibitor Refractory Patients: Results of the Phase I Stomp Trial
Bahlis, Nizar J., Kotb, Rami, Sebag, Michael, Sutherland, Heather J., LeBlanc, Richard, White, Darrell, Venner, Christopher P., Kouroukis, Tom, Bergstrom, Debra, McCurdy, Arleigh, Lalancette, Marc, Bensinger, William, Lentzsch, Suzanne, Del Col, Aldo, Kauffman, Michael, Shacham, Sharon, Jeha, Jacqueline, Picklesimer, Carla, Saint-Martin, Jean-Richard, Choe-Juliak, Cassandra, Chen, Christine
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Selinexor and Low Dose Dexamethasone (Sd) in Patients with Lenalidomide, Pomalidomide, Bortezomib, Carfilzomib and Anti-CD38 Ab Refractory Multiple Myeloma (MM): STORM Study
Vogl, Dan T., Dingli, David, Cornell, R. Frank, Huff, Carol Ann, Jagannath, Sundar, Bhutani, Divaya, Baz, Rachid, Nooka, Ajay K, Richter, Joshua, Cole, Craig E., Vij, Ravi, Jakubowiak, Andrzej, Abonour, Rafat, Schiller, Gary J., Parker, Terri L., Costa, Luciano J., Kaminetzky, David, Hoffman, James, Yee, Andrew J., Chari, Ajai, Siegel, David S., Fonseca, Rafael, VanWier, Scott, Ahmann, Gregory, Lopez, Ilsel, Kauffman, Michael, Shacham, Sharon, Saint-Martin, Jean-Richard, Picklesimer, Carla, Friedlander, Sharon, Choe-Juliak, Cassandra, Stewart, A. Keith
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Oral Selinexor Shows Single Agent Activity Enhanced With PI or IMID Combinations in Refractory Multiple Myeloma (MM)
Lonial, Sagar, Vogl, Dan T, Chen, Christine, Jakubowiak, Andrzej, Kauffman, Michael, Shacham, Sharon, Choe-Juliak, Cassandra, Gardner, Humphrey, Bahlis, Nizar J
Published in Clinical lymphoma, myeloma and leukemia (01.02.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.02.2017)
Get full text
Journal Article